Timothy R. Wright is a businessperson who founded Mortimer Capital and who has been at the helm of 7 different companies.
He is Chief Executive Officer & Director at MiMedx Group, Inc.
He is also on the board of Agenus, Inc. and Ohio State Innovation Foundation and Partner at Signal Hill Advisors LLC.
In his past career Timothy R. Wright was Chairman & Chief Executive Officer of Curaxis Pharmaceutical Corp., President & Interim Chief Executive Officer at AAIPharma, Inc., President & Chief Executive Officer for M2Gen Corp., Chief Operating Officer for Xanodyne Pharmaceuticals, Inc., Senior Vice President-Healthcare Product Services at Cardinal Health, Inc., Executive VP-Strategy & Business Development at Teva Pharmaceutical Industries Ltd., Chairman for ParagonRx International LLC, Director at Ohio State University Comprehensive Cancer Center, President at Elan Biopharmaceuticals, Inc., SVP-Strategy & Corporate Business Development at DuPont Merck Pharmaceutical Co., President-Pharmaceuticals & Senior Vice President at Covidien New Zealand Ltd. and President-Pharmaceuticals & Senior Vice President at Covidien Ltd.
He received an undergraduate degree from The Ohio State University.